Procter and Gamble to resume manufacturing, sale of Vicks Action 500 Extra
Procter & Gamble | March 16, 2016
EW DELHI: FMCG firm Procter and GambleBSE 1.47 % (P&G) today said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs. "The company would resume manufacture and sale of Vicks Action 500 Extra," P&G said in a statement. The company had discontinued manufacture and sale of Vicks Action 500 Extra. Government has banned medicines including Vicks Action 500 Extra as part of its decision to stop the manufacture and sale of fixed dose combination drugs (FDCs).